Frontlight ResearchEarly access
Not yet taking people in NetherlandsPhase 2
New scan using 68Ga-Pentixafor to look for heart sarcoidosis
Tests how accurately a 68Ga-Pentixafor scan shows sarcoidosis in the heart.
Key facts
- Who runs it
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Where
- Rotterdam, NetherlandsSee the site
- Trial code
- Registry title
- New PET/CT for (possible) cardiac sarcoidosis
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 20 people, planned
- Started
- 1 Feb 2026
- Expected to end
- 1 Feb 2027
- Type of study
- Interventional
- Record updated
- 18 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with sarcoidosis outside the heart who may also have sarcoidosis in the heart. It tests a new PET/CT scan called 68Ga-Pentixafor PET/CT.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- A confirmed diagnosis of sarcoidosis outside the heart, and known or suspected sarcoidosis of the heart. People must already be sent for an 18F-FDG PET/CT scan for medical reasons.
Main reasons for not taking part
- Another known infection or inflammatory disease of the heart in the past
- Pregnancy or possible pregnancy in women who have not reached menopause
- Not wanting to be told about other findings the PET/CT scan may show
- Not able to give informed consent
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Adult patients (aged 18 years or older)
- Consensus diagnosis of extracardiac sarcoidosis
- Patients with (suspected) cardiac sarcoidosis referred for a clinically indicated 18F-FDG PET/CT
Who cannot take part
- Medical history of other known cardiac infectious or inflammatory disease
- (Possible) pregnancy in pre-menopausal women
- Refusal to be informed about potential additional PET/CT findings
- Inability to provide informed consent
Where in Netherlands
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
To evaluate the accuracy of 68Ga-Pentixafor PET/CT in imaging CS in a pilot study.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Accuracy for Imaging Cardiac Sarcoidosis with 68Ga-Pentixafor Positron Emission Tomography/Computed Tomography (68Ga-Pentixafor PET/CT): ASPECT study
- Plain-language title
- New scan using 68Ga-Pentixafor to look for heart sarcoidosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 18 June 2026